A poxvirus (modified vaccinia Ankara) vector expressing the carboxy portion of EBV EBNA1 and an inactivated form of EBV LMP2 was developed to treat patients with nasopharyngeal carcinoma. The gene discussed is PSMB9; the disease is nasopharyngeal carcinoma.